{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:50Z","timestamp":1746417770661,"version":"3.40.4"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Our aim was to analyze characteristics of atrial fibrillation (AF) patients with chronic kidney disease (CKD) from the Croatian cohort of the ESH A Fib survey and to determine the association of estimated glomerular filtration rate (eGFR) with cardiovascular (CV) mortality after 24 months of follow-up.<\/jats:p>\n            <jats:p>Consecutive sample of 301 patients with AF were enrolled in the period 2014 to 2018. Hypertension was defined as BP &gt;\u200a140\/90 mm Hg and\/or antihypertensive drugs treatment, CKD was defined as eGFR (CKD Epi) &lt;\u200a60\u200aml\/min\/1.73\u200am<jats:sup>2<\/jats:sup> which was confirmed after 3 months.<\/jats:p>\n            <jats:p>CKD was diagnosed in 45.2% of patients (13.3% in CKD stage &gt;\u200a3b). CKD patients were older than non-CKD and had significantly more frequent coronary heart disease, heart failure and valvular disease. CKD patients had significantly higher CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score and more CKD than non-CKD patients had CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc &gt;\u200a2. Crude CV mortality rate per 1000 population at the end of the first year of the follow-up was significantly higher in CKD vs non-CKD group who had shorter mean survival time. CV mortality was independently associated with eGFR, male gender, CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VASc and R<jats:sub>2<\/jats:sub>CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VASc scores.<\/jats:p>\n            <jats:p>Prevalence of CKD, particularly more advanced stages of CKD, is very high in patients with AF. Observed higher CV mortality and shorter mean survival time in CKD patients could be explained with higher CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VASc score which is a consequence of clustering of all score components in CKD patients. However, eGFR was independently associated with CV mortality. In our cohort, R<jats:sub>2<\/jats:sub>CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VASc score was not associated significantly more with CV mortality than CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>VASc score.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023975","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T16:05:01Z","timestamp":1610640301000},"page":"e23975","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6264-6809","authenticated-orcid":false,"given":"Vedran","family":"Premu\u017ei\u0107","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb"},{"name":"School of Medicine, Zagreb, Croatia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranko","family":"Stevanovi\u0107","sequence":"additional","affiliation":[{"name":"Croatian Public Health Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Radi\u0107","sequence":"additional","affiliation":[{"name":"University Hospital Center Sisters of Mercy, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Salvetti","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of Brescia, Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Lovri\u0107-Ben\u010di\u0107","sequence":"additional","affiliation":[{"name":"Cardiology Clinic, University Hospital Center Zagreb"},{"name":"School of Medicine, Zagreb, Croatia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Jelakovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davor","family":"Mili\u010di\u0107","sequence":"additional","affiliation":[{"name":"Cardiology Clinic, University Hospital Center Zagreb"},{"name":"School of Medicine, Zagreb, Croatia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krunoslav","family":"Capak","sequence":"additional","affiliation":[{"name":"Croatian Public Health Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Agabiti-Rosei","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of Brescia, Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojan","family":"Jelakovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb"},{"name":"School of Medicine, Zagreb, Croatia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ki.2011.416","article-title":"The prevalence of and factors associated with chronic atrial fibrillation in Medicare\/Medicaid-eligible dialysis patients","volume":"81","author":"Wetmore","year":"2012","journal-title":"Kidney Int"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2005.07.044","article-title":"Prevalence of atrial fibrillation and associated factors in a population of longterm hemodialysis patients","volume":"46","author":"Genovesi","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"key":"R6-20250504","first-page":"275A","article-title":"Arrhythmic risk in patients with type II diabetes on hemodialysis: preliminary results from the Monitoring in Dialysis (MiD) Clinical Study","volume":"26","author":"Roy-Chaudhury","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e0169400","DOI":"10.1371\/journal.pone.0169400","article-title":"Prevalence of atrial fibrillation and antithrombotic therapy in hemodialysis patients: cross-sectional results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)","volume":"12","author":"Konigsbrugge","year":"2017","journal-title":"PLoS One"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","article-title":"Conference Participants. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"39","author":"Turakhia","year":"2018","journal-title":"Eur Heart J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e001303","DOI":"10.1161\/JAHA.114.001303","article-title":"Incident atrial fibrillation and risk of death in adults with chronic kidney disease","volume":"3","author":"Bansal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"ATRIA Study Investigators. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000046216","article-title":"Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation","volume":"21","author":"Wiesholzer","year":"2001","journal-title":"Am J Nephrol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1067\/mhj.2000.111111","article-title":"Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis","volume":"140","author":"Vazquez","year":"2000","journal-title":"Am Heart J"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1160\/TH13-01-0054","article-title":"Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?","volume":"109","author":"Roldan","year":"2013","journal-title":"Thromb Haemost"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.jacc.2013.02.035","article-title":"Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project","volume":"61","author":"Banerjee","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"h246","DOI":"10.1136\/bmj.h246","article-title":"The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study","volume":"350","author":"Jun","year":"2015","journal-title":"BMJ"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1378\/chest.15-1719","article-title":"Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies","volume":"149","author":"Dahal","year":"2016","journal-title":"Chest"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.annepidem.2012.12.011","article-title":"Atrial fibrillation and risk of stroke in dialysis patients","volume":"23","author":"Wetmore","year":"2013","journal-title":"Ann Epidemiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/europace\/euv289","article-title":"Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis","volume":"18","author":"Chan","year":"2016","journal-title":"Europace"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.hrthm.2014.06.021","article-title":"Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis","volume":"11","author":"Chao","year":"2014","journal-title":"Heart Rhythm"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.112.107128","article-title":"ROCKET AF Steering Committee and Investigators. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts","volume":"127","author":"Piccini","year":"2013","journal-title":"Circulation"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/eurheartj\/ehu139","article-title":"Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study","volume":"36","author":"Friberg","year":"2015","journal-title":"Eur Heart J"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.2215\/CJN.03110410","article-title":"The CKD-EPI equation for estimating GFR from serum creatinine: real improvement or more of the same?","volume":"5","author":"Rule","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","article-title":"Task Force for the Management of Arterial, Hypertension., Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC):, ESH\/ESC., Task Force for the Management of Arterial, Hypertension","volume":"31","year":"2013","journal-title":"J Hypertens"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/EDE.0000000000000018","article-title":"Net reclassification indices for evaluating risk prediction instruments: a critical review","volume":"25","author":"Kerr","year":"2014","journal-title":"Epidemiology"},{"key":"R26-20250504","first-page":"1570","volume":"41","author":"Proietti","year":"2018","journal-title":"ATAAF Investigators Glomerular filtration rate: A prognostic marker in atrial fibrillation\u2014A subanalysis of the AntiThrombotic Agents Atrial Fibrillation Clin Cardiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/ene.12293","article-title":"Association between reduced kidney function and clinical outcomes after ischaemic stroke with atrial fibrillation","volume":"21","author":"Wang","year":"2014","journal-title":"Eur J Neurol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2215\/CJN.03170509","article-title":"Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease","volume":"5","author":"Ananthapanyasut","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/ijcp.12379","article-title":"Renal function, attributes and coagulation treatment in atrial fibrillation (R-FACT Study): retrospective, observational, longitudinal cohort study of renal function and antithrombotic treatment patterns in atrial fibrillation patients with documented eGFR in real-world clinical practices in Germany","volume":"68","author":"Wu","year":"2014","journal-title":"Int J Clin Pract"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/ene.12528","article-title":"Prevalence of renal dysfunction in ischaemic stroke and transient ischaemic attack patients with or without atrial fibrillation","volume":"22","author":"Laiblea","year":"2015","journal-title":"Eur J Neurol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.amjcard.2018.04.049","article-title":"Usefulness of the addition of renal function to the CHA2DS2-VASc score as a predictor of thromboembolism and mortality in patients without atrial fibrillation","volume":"122","author":"Parsons","year":"2018","journal-title":"Am J Cardiol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2018.11.098","article-title":"Comparison of atrial fibrillation in CKD and non-CKD populations: a cross-sectional analysis from the Kailuan study","volume":"277","author":"Guo","year":"2019","journal-title":"Int J Cardiol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.2014.195","article-title":"AFNET Study Group. Morbidity and treatment in patients with atrial fibrillation and chronic kidney disease","volume":"87","author":"Reinecke","year":"2015","journal-title":"Kidney Int"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjcard.2010.10.074","article-title":"Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation","volume":"15","author":"Nakagawa","year":"2011","journal-title":"Am J Cardiol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.020","article-title":"Impaired renal function in stroke patients with atrial fibrillation","volume":"23","author":"Sauer","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ehjqcco\/qcx032","article-title":"J-RHYTHM Registry Investigators. J-RHYTHM Registry Investigators. Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry","volume":"4","author":"Kodani","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.V1071606","article-title":"The clinical epidemiology of cardiac disease in chronic renal failure","volume":"10","author":"Parfrey","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jcmg.2012.06.007","article-title":"Coronary vascular dysfunction and prognosis in patients with chronic kidney disease","volume":"5","author":"Murthy","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1681\/ASN.2006040367","article-title":"Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease","volume":"18","author":"Tatematsu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/ndt\/16.10.1968","article-title":"Endothelial dysfunction and inflammation: is there a link?","volume":"16","author":"Stenvinkel","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.amjcard.2017.04.054","article-title":"Prognostic implications of left ventricular global longitudinal strain in predialysis and dialysis patients","volume":"120","author":"Hensen","year":"2017","journal-title":"Am J Cardiol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.119.043916","article-title":"Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in patients with chronic kidney impairment","volume":"141","author":"Bajaj","year":"2020","journal-title":"Circulation"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1093\/eurheartj\/eht328","article-title":"Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial","volume":"34","author":"Apostolakis","year":"2013","journal-title":"Eur Heart J"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1253\/circj.CJ-13-1246","article-title":"Impact of renal dysfunction on clinical outcome in patients with low risk of atrial fibrillation","volume":"78","author":"Lin","year":"2014","journal-title":"Circ J"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic renal insufficiency cohort (CRIC) study group. chronic kidney disease and prevalent atrial fibrillation","volume":"159","author":"Soliman","year":"2010","journal-title":"Am Heart J"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States: Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"4","author":"Baber","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:23:35Z","timestamp":1746339815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023975"}},"subtitle":["European Society of Hypertension project \u2013 ESH A Fib"],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023975","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"2020-07-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}